Idexx enables improved cancer diagnosis and personalized care through expanded oncology offering

Westbrook, maine, jan. 13, 2022 /prnewswire/ -- idexx laboratories, inc. (nasdaq: idxx), a global leader in pet healthcare innovation, announced today the expansion of its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. building on its expertise in cancer pathology, idexx continues to expand what's possible to enhance the lives of pets by providing veterinarians with comprehensive cancer diagnostics and support services.
IDXX Ratings Summary
IDXX Quant Ranking